Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001171843-17-006258

Options or other derivatives

  • CFO & COO acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MORTIMER IAN · CFO & COO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-10-23 Grant or award : show line 1 in the form Stock Option (Right to Buy) +25,000 $3.10 2027-10-22 25,000 25,000 D
Loading xslF345X03/form4mortimer.xml…